Cargando…
Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance
Direct acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) treatment, but drug resistance could undermine proposed global elimination targets. Real‐world studies are needed to inform the impact of widespread DAA treatment on antiviral resistance in the community. The prevalence and...
Autores principales: | Douglas, Mark W., Tay, Enoch S.E., Wang, Dao Sen, Ong, Adrian T.L., Wilson, Caroline, Phu, Amy, Kok, Jen, Dwyer, Dominic E., Bull, Rowena A., Lloyd, Andrew R., Applegate, Tanya L., Dore, Gregory J., Howe, Anita Y., Harrigan, Richard, George, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262285/ https://www.ncbi.nlm.nih.gov/pubmed/32490325 http://dx.doi.org/10.1002/hep4.1496 |
Ejemplares similares
-
Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment
por: Eltahla, Auda A., et al.
Publicado: (2017) -
Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A systematic review
por: Bartlett, Sofia R., et al.
Publicado: (2017) -
The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis
por: Lamoury, François M. J., et al.
Publicado: (2015) -
An Amplicon-Based Approach for the Whole-Genome Sequencing of Human Metapneumovirus
por: Tulloch, Rachel L., et al.
Publicado: (2021) -
Molecular diagnosis of respiratory viruses
por: Somerville, Lucy K., et al.
Publicado: (2015)